Rising burden of chronic kidney disease attributable to high fasting plasma glucose in the Middle East and North Africa, 1990-2023

Introduction

Chronic kidney disease (CKD) attributable to high fasting plasma glucose (HFPG) is rising globally, particularly in regions with rapidly increasing dysglycemia such as the Middle East and North Africa (MENA). We assessed long-term trends in HFPG-attributable CKD burden across 21 MENA countries from 1990 to 2023.